Pirtobrutinib
Product Specifications
CAS Number
2101700-15-4
Target
BTK
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.9994
Bioactivity
Pirtobrutinib (LOXO-305) is an advanced BTK inhibitor that displays high selectivity and operates through a non-covalent mechanism. This compound effectively inhibits various BTK C481 substitution mutations, leading to tumor regression in BTK-dependent lymphoma tumors in mouse xenograft models. Furthermore, Pirtobrutinib exhibits remarkable selectivity for BTK, with more than a 300-fold difference compared to 370 other kinases tested. Notably, at a concentration of 1 μM, Pirtobrutinib demonstrates no significant inhibition of non-kinase off-targets.
Smiles
COc1ccc(F)cc1C(=O)NCc1ccc(cc1)-c1nn([C@@H](C)C(F)(F)F)c(N)c1C(N)=O
Molecular Formula
C22H21F4N5O3
Molecular Weight
479.43
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472853-100 1x 100 µL
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP20782PU-N 100 µg
67kDa Laminin Receptor (RPSA) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
#20993-50uL 1x 50 µL
CF®498 Donkey Anti-Guinea Pig IgG (H+L), Highly Cross-Adsorbed, single label for STORM 1 mg/mL
Sign In for Pricing
View Details 